Anti-TAK1 antibody [EPR5984]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
4
(2 Reviews)
|
(81 Publications)
Rabbit Recombinant Monoclonal TAK1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Mouse, Rat samples. Cited in 81 publications.
View Alternative Names
TAK1, MAP3K7, Mitogen-activated protein kinase kinase kinase 7, Transforming growth factor-beta-activated kinase 1, TGF-beta-activated kinase 1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TAK1 antibody [EPR5984] (AB109526)
ab109526, at a 1/50 dilution, staining TAK1 in Formalin/PFA-fixed paraffin-embedded Human brain tissue, by Immunohistochemistry.
Perform heat mediated antigen retrieval via the microwave method before commencing with IHC staining protocol.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-TAK1 antibody [EPR5984] (AB109526)
ab109526 staining TAK1 in wild-type HAP1 cells (top panel) and TAK1 knockout HAP1 cells (bottom panel). The cells were fixed with 4% formaldehyde (10min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab109526 at 1/1000 dilution and ab195889 at 1/250 dilution (shown in pseudo colour red) overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-TAK1 antibody [EPR5984] (AB109526)
Intracellular Flow Cytometry analysis of A431 (human epidermoid carcinoma) cells labeling TAK1 with unpurified ab109526 at 1/20 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) was used as the unlabeled control.
- WB
Lab
Western blot - Anti-TAK1 antibody [EPR5984] (AB109526)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : TAK1 knockout HAP1 cell lysate (20 μg)
Lane 3 : SHSY5Y cell lysate (20 μg)
Lane 4 : A431 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab109526 observed at 72 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab109526 was shown to specifically react with TAK1 when TAK1 knockout samples were used. Wild-type and TAK1 knockout samples were subjected to SDS-PAGE. ab109526 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-TAK1 antibody [EPR5984] (ab109526)
Predicted band size: 67 kDa
false
- WB
Lab
Western blot - Anti-TAK1 antibody [EPR5984] (AB109526)
Lanes 1- 2 : Merged signal (red and green). Green - ab109526 observed at 72 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab109526 was shown to react with TAK1 in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266555 (knockout cell lysate ab256984) was used. Wild-type HEK-293T and MAP3K7 knockout HEK-293T cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab109526 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TAK1 antibody [EPR5984] (ab109526) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
MAP3K7 knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human MAP3K7 (TAK1) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-map3k7-tak1-knockout-hek-293t-cell-line-ab266555'>ab266555</a>)
Predicted band size: 35 kDa,36 kDa,43 kDa,47 kDa,60 kDa,67 kDa,74 kDa
Observed band size: 36 kDa,60 kDa,72 kDa,95 kDa
false
- WB
Unknown
Western blot - Anti-TAK1 antibody [EPR5984] (AB109526)
All lanes:
Western blot - Anti-TAK1 antibody [EPR5984] (ab109526) at 1/1000 dilution
Lane 1:
K562 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
A431 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled Goat anti-Rabbit IgG at 1/2000 dilution
Predicted band size: 67 kDa
Observed band size: 75 kDa
false
- WB
Lab
Western blot - Anti-TAK1 antibody [EPR5984] (AB109526)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TAK1 antibody [EPR5984] (ab109526) at 1/1000 dilution
Lane 1:
Mouse brain tissue lysate at 20 µg
Lane 2:
Mouse heart tissue lysate at 20 µg
Lane 3:
Mouse spleen tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 75 kDa
false
Exposure time: 48s
- WB
Lab
Western blot - Anti-TAK1 antibody [EPR5984] (AB109526)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TAK1 antibody [EPR5984] (ab109526) at 1/1000 dilution
Lane 1:
Rat brain tissue lysate at 20 µg
Lane 2:
Rat kidney tissue lysate at 20 µg
Lane 3:
Rat spleen tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 75 kDa
false
Exposure time: 180s
Related conjugates and formulations (2)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-TAK1 antibody [EPR5984]
-
Anti-TAK1 antibody [EPR5984] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TAK1 is involved in several cellular processes necessary for maintaining balance and responding to stress. TAK1 forms a complex with proteins like TAB1 TAB2 and TAB3 which are important for its activation and signaling function. This complex facilitates TAK1's involvement in inflammation and immune response indicating its significance in mediating cellular survival and apoptosis.
Pathways
TAK1 operates within the NF-κB and MAPK pathways two critical routes for cellular response to inflammation and stress. In the NF-κB pathway TAK1 activates IKK which triggers the degradation of IκB freeing NF-κB to move into the nucleus and activate transcription. In the MAPK pathway TAK1 directly influences JNK and p38 cascades revealing regulatory connections to proteins like MEK and ERK.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (81)
Recent publications for all applications. Explore the full list and refine your search
Drug design, development and therapy 19:8843-8864 PubMed41049040
2025
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2025:4932970 PubMed40918406
2025
Applications
Unspecified application
Species
Unspecified reactive species
Virology journal 22:101 PubMed40241182
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:1890 PubMed39987261
2025
Applications
Unspecified application
Species
Unspecified reactive species
Microbiology spectrum 13:e0162624 PubMed39932324
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 138: PubMed39584231
2024
Applications
Unspecified application
Species
Unspecified reactive species
Central-European journal of immunology 49:393-403 PubMed39944262
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:21106 PubMed38036641
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:6699 PubMed37872167
2023
Applications
Unspecified application
Species
Unspecified reactive species
Aging and disease 14:1799-1817 PubMed37196118
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com